Vadimezan  |
| |
| Klinički podaci |
| AHFS/Drugs.com | Monografija |
| Identifikatori |
| CAS broj | 117570-53-3 |
| ATC kod | nije dodeljen |
| UNII | 0829J8133H  Y |
| ChEBI | CHEBI:75934 Y |
| Hemijski podaci |
| Formula | C17H14O4 |
| Mol. masa | 282,291 |
| SMILES | eMolekuli & PubHem |
| InChI |
|---|
InChI=1S/C17H14O4/c1-9-6-7-13-15(20)12-5-3-4-11(8-14(18)19)17(12)21-16(13)10(9)2/h3-7H,8H2,1-2H3,(H,18,19)
Key: XGOYIMQSIKSOBS-UHFFFAOYSA-N Y | |
| Sinonimi | ASA404, DMXAA |
| Farmakoinformacioni podaci |
| Trudnoća | ? |
| Pravni status | |
Vadimezan je organsko jedinjenje, koje sadrži 17 atoma ugljenika i ima molekulsku masu od 282,291 Da.
Osobine
Reference
- ↑ Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o.
- ↑ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.
- ↑ Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.
Literatura
- Hardman JG, Limbird LE, Gilman AG. (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10 izd.). New York: McGraw-Hill. DOI:10.1036/0071422803. ISBN 0-07-135469-7.
- Thomas L. Lemke, David A. Williams, ur. (2007). Foye's Principles of Medicinal Chemistry (6 izd.). Baltimore: Lippincott Willams & Wilkins. ISBN 0-7817-6879-9.
Spoljašnje veze
 | Portal Medicina |
 | Portal Hemija |
Vadimezan na Wikimedijinoj ostavi
Y 
